ALSSF (ALSSF) Stock Price & Analysis
ALSSF (ALSSF) rose 0.00% to USD 2.3 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
ALSSF last closed at USD 2.3; the session ranged USD 2.24–2.36 on volume of 3,600 shares. Market capitalization is $1.83B, with a 52-week range of USD 2.24–3.69 (PNK). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 2.3 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 2.3 |
| Open | USD 2.33 |
| Day Range | USD 2.24 – 2.36 |
| 52-Week Range | USD 2.24 – 3.69 |
| Volume | 3,600 shares |
| Market Cap | $1.83B |
| Exchange | PNK |
Technical Analysis (ALSSF)
Nexqual's technical model rates ALSSF "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 21.06 (oversold) |
| vs SMA50 | Below (USD 2.7) |
| MACD | -0.12 (negative) |
Analyst Ratings (ALSSF)
Wall Street analysts rate ALSSF "None", per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|
Earnings (ALSSF)
| Next Earnings Date | 2026-10-21 |
|---|---|
| Revenue Estimate | $21.79B |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (ALSSF)
| Total Revenue | $85.04B |
|---|---|
| Revenue Growth (YoY) | -1.80% |
| Gross Margin | +34.63% |
| Operating Margin | +9.96% |
| Profit Margin | +1.76% |
| ROE | +20.22% |
| Debt / Equity | 603.91 |
| Current Ratio | 0.71 |
| Total Cash | $5.49B |
| Total Debt | $50.42B |
| Free Cash Flow | $5.26B |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (ALSSF)
Nexqual rates ALSSF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 35%, operating 10% |
| Balance Sheet | Critical — $5.49B cash vs $50.4B debt |
| Cash Flow | Solid — FCF $5.26B, 6% margin |
| Efficiency | Strong — ROE 20%, ROA 6.6% |
Ownership (ALSSF)
| Insider Ownership | +39.61% |
|---|---|
| Institutional Ownership | +24.95% |
| Shares Outstanding | 795.04M |
| Float | 434.58M |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Leadership (ALSSF)
ALSSF is led by Christian Gurria Dubernard, Chief Executive Officer, per Nexqual as of July 25, 2026 at 02:21 UTC.
| Chief Executive Officer | Christian Gurria Dubernard |
|---|---|
| Chairman & President | Armando Torrado Martinez (age 56) |
| Founder & Director | Alberto Torrado Martinez (age 62) |
| CFO and Director of Administration & Finance | Engineer Federico Rodríguez Rovira (age 44) |
| Investor Relations & Corporate Affairs Director | Gerardo Lozoya Lapati |
Major Backers & Investors (ALSSF)
Notable institutional backers of ALSSF include DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT., American Century ETF Trust-Avantis Emerging Markets Equity ETF, Mexico Fund Inc, according to Nexqual as of July 25, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT. | 0.53% |
| American Century ETF Trust-Avantis Emerging Markets Equity ETF | 0.24% |
| Mexico Fund Inc | 0.21% |
| Schwartz Investment Trust-Ave Maria World Equity Fund | 0.11% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.94% |
| BlackRock | 1.5% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TPZEF | TOPAZ ENERGY CORP. | USD 23.32 | ▲ 0.73% |
| BFFAF | BASF SE | USD 55.39 | ▲ 0% |
| AIMFF | Aimia, Inc. | USD 1.83 | ▲ 0.55% |
| ACXIF | Acciona S.A. | USD 284.13 | ▼ 2.99% |
| ALPMF | Astellas Pharma, Inc. | USD 12.85 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.